GlycoEra raised $130m in Series B led by Novo, joined by Catalio Capital, LifeArc Ventures, QIA, Sixty Degree Capital, Agent Capital, MP Healthcare, Sofinnova. Biotech Health services Pharma Investments 17 May 2025 Share: Interested in more dealflow and deeper data sets from Europe? Please consider joining Nordic 9!
Round value (USD): 130M Round investors: Novo A/SCatalio Capital ManagementRoche Venture FundLifeArc VenturesQatar Investment AuthorityAgent CapitalSixty Degree Capital5AM VenturesSofinnova PartnersMP Healthcare Venture Management Company: GlycoEra Industry: BiotechHealth servicesPharma
Hemab raised $157m Series C led by Sofinnova, joined by Avoro Capital, RA Capital, Novo, Access Biotechnology, Deep Track, HealthCap, Invus, Maj Invest Biotech Health services Investments 16 October 2025
ImCheck Therapeutics to be acquired by pharmaceutical company Ipsen for a total potential consideration up to €1 billion Biotech Health services Pharma M&A 12 October 2025
Nexthink in a $3.2 billion acquisition with Vista Equity Partners. Software Services Secondary 08 October 2025
General Intuition raised a $133.7M seed round from Khosla Ventures, General Catalyst, and Raine AI (big data) Software Services Investments 05 October 2025
Tubulis raised €308 million in a Series C funding round co-led by Venrock, Wellington Management, and Ascenta Capital, Biotech Health services Investments 03 October 2025